Sabine A. Meijvis

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic Review.

Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic Review.

Journal: JAMA network open

Published: March 07, 2024

The position of renal denervation in treatment of hypertension: an expert consensus statement.

The position of renal denervation in treatment of hypertension: an expert consensus statement.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: August 01, 2022

Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map.

Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map.

Journal: Systematic reviews

Published: February 02, 2022

The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients.

The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients.

Journal: BMC nephrology

Published: April 20, 2021

Fosfomycin-trometamol for Urinary Tract Infections in Kidney Transplant Recipients.

Fosfomycin-trometamol for Urinary Tract Infections in Kidney Transplant Recipients.

Journal: Transplantation

Published: August 22, 2018

Mannose-binding lectin and l-ficolin polymorphisms in patients with community-acquired pneumonia caused by intracellular pathogens.

Mannose-binding lectin and l-ficolin polymorphisms in patients with community-acquired pneumonia caused by intracellular pathogens.

Journal: Immunology

Published: September 06, 2016

Antipyretic effect of dexamethasone in community-acquired pneumonia.

Antipyretic effect of dexamethasone in community-acquired pneumonia.

Journal: The European respiratory journal

Published: December 07, 2014

Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples.

Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples.

Journal: BMC infectious diseases

Published: August 21, 2014

Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands.

Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands.

Journal: Epidemiology and infection

Published: November 16, 2013

Incidence and predictive value of proteinuria in community-acquired pneumonia.

Incidence and predictive value of proteinuria in community-acquired pneumonia.

Journal: Nephron. Clinical practice

Published: October 14, 2012

Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia.

Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 04, 2012

Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia.

Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia.

Journal: Clinical and vaccine immunology : CVI

Published: August 03, 2012

Showing 1-12 of 20

Last Updated: 09/26/2026